For PFS, ATP1B3 expression was significantly hazardous to HCC patients with stage I, grade II, T 1, none-vascular invasion, female, Asian, and Hepatitis virus (Table 1). This evidence concerns the gene ATP1B3 and hepatocellular carcinoma.